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INTRODUCTION 
Physical and Chemical Methods of Cholesterol Reduction 
Consumer demand for foods which are lower in cholesterol has stimulated 
research in the development of physical, chemical and biological technologies to 
decrease the amounts of cholesterol and triacylglycerols in foods (Arima et al , 
1969; Bjorkhem et al. , 1973; Dehal et al., 1991; Johnson and Somkuti , 1990; 
Marshek et al., 1972; Mazschner and Fine, 1989}. Physical methods, such as 
steam-stripping have shown promise in that over 90% of cholesterol from butter oil 
and lard was removed without imparting off flavors to the products tested (Sperber, 
1989). Supercritical extraction of cholesterol with carbon dioxide has also been 
successful to decrease the level of cholesterol in butterfat by 90% or more 
(Sperber, 1989; Randolph et al., 1988; Froning et al. , 1990). Although both of the 
above mentioned methods show promise, neither has come into widespread use 
due to the problems of cost-efficiency and limited food types that can be processed. 
Other methods of cholesterol reduction in foods currently being investigated 
include the addition of high-molecular-weight hydroxypropylmethylcellulose to 
diets of hypercholesteremic patients and the enhanced degradation of cholesterol 
in the presence of cyclodextrins (Dressman et al. , 1993; Jadoun and Bar, 1993). 
Biological methods to reduce levels of cholesterol have also been 
investigated. These methods are advantageous in that they are less harsh on the 
products being treated, form fewer byproducts, are easier to control , and are 
considered more "natural" by consumers. Bacteria which degrade cholesterol 
have been studied for quite some time. Two types of bacterial cholesterol 
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degradation systems have been identified; a cholesterol oxidase system and a 
cholesterol reductase system (Stadtman et al. , 1954; Smith and Brooks, 1976; 
Molnar et al. , 1993; Noma and Nakayama, 1976; Brigidi et al. 1993; Snog-Kjaer et 
al., 1956; Bjorkhem et al. , 1973; Rosenfeld and Gallagher, 1964; Wilkins and 
Hackman, 1974; Eyssen et al. , 1973; Freier et al. 1994). Both methods of bacterial 
cholesterol reduction have shown promise in potential commercial applications. 
Thesis Organization 
This thesis consists of an introduction, literature review, one manuscript that 
will be submitted for publication, a summary and discussion, and 
acknowledgments. The literature cited for both the literature review and manuscript 
are listed in a single "literature cited" section. The master degree candidate, 
Ronald Guy Lulich, is the senior author and principal investigator for the 
manuscript. 
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LITERATURE REVIEW 
Bacterial Oxidation of Cholesterol 
Oxidation of cholesterol occurs in a number of species of bacteria (Turfitt, 
1946; Noma and Nakayama, 1976; Smith and Brooks, 1976; Smith and Brooks, 
1974; Ferreira et al., 1984; Smith et al., 1993). The cholesterol-oxidizing enzyme 
has been given several names including: cholesterol oxidase, cholesterol: 0 2 
oxidoreductase, and 3B-hydroxysteroid oxidase based upon cofactor requirements 
and substrate specificities (Noma and Nakayama, 1976; Smith and Brooks, 1977; 
Turfitt, 1948; Uwajima et al. , 1974; Molnar et al. , 1993). Cholesterol oxidase 
catalyzes two different reactions. Cholesterol is oxidized to 5-cholesten-3-one, a 
transient intermediate, while at the same time, molecular oxygen is reduced to 
hydrogen peroxide. The stoichiometry of the reaction is 1 :1 with one mole of 
hydrogen peroxide produced per mole of cholesterol oxidized (Stadtman et al. , 
1954; Uwajima et al., 1974; Richmond, 1973; Vrielink et al. , 1991 ). 
The next step involves an isomerization of the .'.15- .'.16 bond by a related .'.15-3-
ketosteroid isomerase resulting in the production of 4-cholesten-3-one as a final 
product (Noma and Nakayama, 1976; Smith and Brooks, 1976; Batzold et al. , 
1976; Kuliopulos et al., 1987). The formation of 4-cholesten-3-one is the first step 
in the catabolism of cholesterol in many bacteria (Turfitt, 1948; Stadtman et al. , 
1954; Smith and Brooks, 1976; Smith et al., 1993). It has been shown that the 
oxidation of the 3B-hydroxyl group is slower than the rate of isomerization of the .'.15-
.'.16 bond, thus making the oxidation the rate-limiting step (Uwajima et al. , 1974; 
Brooks and Smith , 1975; Smith and Brooks, 1976). 
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Cholesterol oxidase exists as a single subunit enzyme with an Mr of 
55,000Da (Uwajima et al. , 1974; Vrielink et al. , 1991 ). The enzyme is comprised of 
two binding domains, one an FAD-binding domain and the other a steroid binding 
region (Vrielink et al., 1991 ). Several hydrophobic loops in the steroid binding site 
are thought to provide a pathway of entry of the steroid into the active-site cavity 
(Vrielink et al., 1991 ). The active site region contains one charged glutamic acid 
residue which is thought to be involved as a proton acceptor in the isomerization 
step of cholesterol oxidation (Uwajima et al. , 1974; Vrielink et al., 1991). 
3B-Hydroxysteroid oxidases have been isolated from other organisms such 
as Streptoverticillium, Schizophyl/um, Brevibacterium, and Nocardia (Smith and 
Brooks, 1977; Fukuyama and Miyake, 1978; Inouye et al., 1982; Vrielink et al. , 
1991 ). The purified enzymes demonstrated similar characteristics placing them 
into the family of enzymes known as cholesterol: 0 2 oxidoreductases (Molnar et 
al. , 1993). 
The cholesterol oxidases that have been characterized display a wide range 
of physical properties. The molecular weights of the purified products ranged from 
31 ,000-32,500 Daltons (Da) for enzymes produced by Brevibacterium while 
enzymes from Streptomyces and Corynebacterium ranged from 56,000 to 61,000 
Da. Spectral analysis of these proteins seems to exhibit a spectrum characteristic 
of a flavoenzyme (Kamei et al., 1978; Noma and Nakayama, 1976; Fukuyama and 
Miyake, 1978; Kenney et al., 1979; Inouye et al., 1982; Smith and Brooks, 1977; 
Vrielink et al., 1991; Molnar et al., 1993). The flavin moiety was identified as flavin 
adenine dinucleotide, and most cholesterol oxidases contain one mole of tightly-
bound flavin adenine dinucleotide per mole of protein as a prosthetic group 
(Uwajima et al. , 1974; Kamei et al., 1978; Kenney et al. , 1979). However, in the 
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case of several species of Nocardia, no flavin adenine dinucleotide cofactor 
purified with active cholesterol oxidase (Richmond, 1973). 
Cholesterol oxidase has high affinity not only for cholesterol, but other 
steroids with a trans A:B ring junction as well (Molnar et al. , 1993; Vrielink et al., 
1991 ). The probable enzymatic reaction consists of an oxidation step followed by, 
in the case of 5-ene steroids, by the isomerization of the Cs-Cs double bond to the 
C4-c5 position (Smith and Brooks, 1976). The KM for cholesterol oxidase isolated 
from various species ranged from 0.14-0.4 mM (Smith and Brooks, 1976; Tomioka 
et al., 1975; Fukuyama and Miyake, 1978; Inouye et al. , 1982; Noma and 
Nakayama, 1976). 
In the analysis of isolated cholesterol oxidases, cholesterol was usually the 
preferred substrate over many other 3-hydroxysteroids (Uwajima, 1974; Tomioka et 
al. , 1975; Noma and Nakayama, 1976; Fukuyama and Miyake, 1978; Kamei et al. , 
1978; Inouye et al., 1982). Steroids lacking the 3B-hydroxyl group generally were 
not oxidized (Smith and Brooks, 1976; Smith and Brooks, 1977; Kamei et al., 1978; 
Uwajima et al., 1974; Inouye et al. , 1982). The lowest rates of oxidation occurred 
when ergosterol was used as a substrate which suggested that a C4-C5 
conjugated bond is less easily oxidized (Smith and Brooks, 1974; Brooks and 
Smith , 1975). Epicholesterol and lanosterol did not serve as substrates (Smith and 
Brooks, 1976). 
Various 4-methyl sterols and 4a- and 4B-hydroxysterols tested were very 
slowly oxidized by the enzyme (Smith and Brooks, 1976). This may be associated 
with the elimination of the 3a- hydrogen atom during oxidation and the hindrance 
of a 4-methyl group during oxidation (Smith and Brooks, 1977). 5a-Cholestan-3B-
ol (cholestanol) appears to be readily oxidized at rates similar to cholesterol , but 
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when the SB-isomer (coprostanol) was added, no oxidation occurred (Brooks and 
Smith, 1975). Extremely low rates of oxidation were also observed for the 3a-
hydroxy epimers of cholesterol and of 4-Cholesten-3B-ol (Brooks and Smith, 1975). 
Variations of the side-chain seem to also play an important role in the rates 
of sterol oxidation (Smith and Brooks, 1976). Sitosterol was readily oxidized; 
however, the introduction of a C22-C23 or C24-C24 double bond decreased the rate 
of oxidation (Smith and Brooks, 1974; Uwajima et al. , 1974; Inouye et al. , 1981 ). A 
study of the oxidation of various hydroxylated cholesterols (26-, 25-, 24-, 22-, and 
20-hydroxycholesterol) yielded mixed results. An additon of the terminal 
substituent in 26-hydroxycholesterol significantly decreased the rate of oxidation of 
the 3B-hydroxyl group, whereas a 24-hydroxyl group significantly stimulated the 
reaction (Brooks and Smith, 1975). 
The length of the side-chain also seems to play an important role in the 
reaction rate of cholesterol oxidase (Richmond, 1973; Smith and Brooks, 1974). 
Kinetic studies were performed with 3B-hydroxysteroids with hydroxylated side-
chains ranging in size from 0-8 carbon atoms and a correlation of Vmax. against 
side-chain length was established. It was shown that the rate of oxidation (Vmax.) of 
5-en-3B-hydroxysteroids increased as side-chain length increased to an optimum 
of 5 carbons with significant oxidation occurring with side-chains up to 8 carbons 
long (Smith and Brooks, 1976; Smith and Brooks, 1974; Richmond, 1973). The 
corresponding KM values in this series indicated no difference in the degree of 
binding (Smith and Brooks, 1976). 
The variations in Vmax as related to side-chain length suggest that the longer 
side-chains of oxidizable compounds could serve to orient the bound sterol or 
steroid so that the 3B-hydroxyl group and the catalytic site are compatibly aligned 
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for oxidation (Smith and Brooks, 1976; Smith and Brooks, 1974; Brooks and Smith, 
1975). The length of the side chain is also important in the binding of steroids to 
the active site during the isomerization reaction (Smith and Brooks, 1977). 
Derivatives of 17-hydroxy and 17-ketosteroids as well as substituted oximes of 
dehydroepiandrosterone, which somewhat simulate the side-chains of 3B-
hydroxysteroids, served as very poor substrates (Smith and Brooks, 1976). 
The gene for the oxidation of cholesterol , choA, was first isolated from 
Streptomyces (Muraoka et al. , 1986). The plasmid-containing DNA inserts coding 
for active cholesterol oxidation were transformed into wild-type strains of S. griseus 
and S. lividans which lacked cholesterol oxidase activity and these 
transformations yielded colonies with cholesterol oxidase activity (Muraoka et al. , 
1986). 
Transformed organisms produced both extracellular and intracellular 
cholesterol oxidase, and it has been shown that the choA gene directs the 
synthesis of both intracellular and extracellular cholesterol oxidase (Muraoka et al. , 
1986). The strain S. lividans, containing the recombinant plasmid plJ 702, 
produced a significant amount of cholesterol oxidase, of which up to 40% was 
secreted extracellularly (Muraoka et al. , 1986). The transformed cells produced 
cholesterol oxidase for up to 8 days and the amount of extracellular enzyme 
increased with culture time while production of intracellular enzyme plateaued at 
around 5 days (Molnar et al. , 1991 ; Muraoka et al., 1986). The continuous 
secretion of the enzyme by the cloned cells has provided a potential for commercial 
large-scale production of cholesterol oxidase. 
Within the N-terminal region of cholesterol oxidase, a high degree of 
sequence homology to alcohol dehydrogenase, p-hydroxybenzoate hydroxylase, 
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and glutathione reductase was found (lshizaki et al. , 1989). In this region of 
homology, the conserved sequences Gly-X-Gly-X-Gly was found characteristic of 
the flavin adenine dinucleotide binding region of flavoproteins and 
dehydrogenases (lshizaki et al. , 1989). 
Another open reading frame 70 base pairs upstream from the choA gene 
was discovered in the search for the promoter region of cholesterol oxidase and 
termed the choP gene (Horii et al. , 1990). The choP gene encodes a protein 
product of 381 amino acids with a molecular weight of 41 ,668 Da (Horii et al. , 
1990). The nucleotide sequence of the choP gene has a high sequence homology 
to cytochrome P-450 genes from humans and cytochrome P-450 genes from 
Pseudomonas species (Horii et al. , 1990). A region of homology with cytochrome 
P-450s was identified in the choP gene and may represent a binding site for heme-
iron (Horii et al., 1990). This was confirmed by CO difference spectral analysis of 
an extract of S. lividans cells transformed with a choP gene-containing plasmid in 
which a unique peak characteristic of cytochrome P-450 was detected (Horii et al. , 
1990). This peak was identical to that found in the parental strains of Streptomyces 
with already-existing cholesterol oxidases (Horii et al. , 1990). 
The new open reading frame is located 70 base pairs upstream from the 
choA gene (Horii et al. , 1990). Data from deletion analysis, nucleotide sequences, 
primer extension mappings, and Northern blot analysis suggest that the choA gene 
is transcribed from the promoter region of the choP gene (Horii et al. , 1990). It has 
been postulated that the choP and choA genes are transcribed both 
polycistronically and from an operon (Horii et al., 1990). This operon has been 
designated the cho operon (Horii et al. , 1990). 
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Another cholesterol oxidase gene, choB, was cloned from Brevibacterium. 
The nucleotide sequence of Brevibacterium was comprised of a single open 
reading frame encoding the 552 amino acid protein preceded by a 45-amino acid 
signal sequence (Ohta et al., 1991; Fujishiro et al., 1990). ChoB showed a 64% 
homology with the structural region within the choA gene from Streptomyces, but 
was dissimilar in the 5' and 3' flanking regions (Ohta et al. , 1991 ; Fujishiro et al., 
1990). ChoB also has the FAD-binding consensus sequence also found in the 
choA gene, but choB lacks any operon or regions of homology with cytochrome P-
450's as in the choP gene (Ohta et al. , 1991 ). The signal sequences for each of the 
two genes varied greatly, but a 58% amino acid sequence homology within the 
structural genes does place the derivation of the two genes to common ancestry 
(Ohta et al. , 1991 ; Horii et al., 1990). 
Cholesterol oxidase has been used in widespread applications, notably its 
use in the determination of total serum cholesterol (Richmond, 1973; Allain et al. , 
1974; Smith and Brooks, 1977). Assay methods for cholesterol oxidase activity 
include quantitation of 4-cholesten-3-one production , evolution of hydrogen 
peroxide coupled to horseradish peroxidase, as well as numerous fluorescence, 
chromatographic and spectral assays (Richmond, 1973; Allain et al. , 1974; Smith 
and Brooks, 1976; Uwajima et al., 1973; Inouye et al. , 1982). 
Cholesterol oxidase enzymes are also being used to lower cholesterol in 
milk and dairy products (Smith et al. , 1991 ). However, several problems have 
developed with the use of cholesterol oxidase in milk to lower dietary cholesterol. 
One problem is the production of hydrogen peroxide which might result in the 
generation of toxic compounds or undesirable flavor components (Smith et al. , 
1991 ). 4-Cholesten-3-one, the principal product from the oxidation of cholesterol , 
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is believed to be toxic because a 5% solution in dimethyl sulfoxide caused nuclear 
aberrations in mouse tissue when instilled intrarectally into mice (Suzuki et al. , 
1986). 
Cholesterol oxidase is also being used in the degradation of egg yolk 
cholesterol in an attempt to produce eggs with lower levels of dietary cholesterol 
(Christodoulou et al., 1994; Johnson and Somkuti, 1990; Aihara et al. , 1988). The 
cholesterol levels in the eggs were reduced by as much as 50% and the oxidation 
occurred over a wide range of temperatures (Christodoulou et al. , 1994). 
Requirements for lower concentrations of enzyme and the ability of cholesterol 
oxidase to degrade egg yolk cholesterol at 4°C make this a promising and practical 
method of dietary cholesterol reduction (Christodoulou et al. , 1994). 
Cholesterol oxidase genes have also been cloned into several Gram-
positive bacteria including Streptococcus thermophi/us , Lactobacil/us casei , L. 
reuteri, several species of Bacillus, and the Gram-negative Escherichia coli (Brigidi 
et al., 1993). Cloning cholesterol oxidase into these commercially important dairy 
and intestinal organisms has provided a potential for safe and effective delivery of 
cholesterol oxidase into food systems for processing (Brigidi et al., 1993). The 
cholesterol oxidase-transformed intestinal bacteria could find potential use as a 
probiotic in the treatment of hypercholesteremia in humans (Brigidi et al. , 1993). 
Unfortunately, the Gram-positive transformants, even though stable, did not show 
cholesterol oxidase activity (Bridigi et al. , 1993). 
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Bacterial Reduction of Steroids and Sterols 
Interest in bacteria which chemically reduce sterols such as cholesterol, 
steroids, and bile acids evolved in response to a need for the understanding of the 
processes involved in the regulation of levels of these sterols and steroids in 
humans. Recently, sterol-reducing bacteria have been again studied in light of 
current research showing the many potential ill-effects of high levels of neutral 
steroids and sterols as related to arteriosclerosis. Isolation and purification of these 
enzymes that convert substrates to commercially important products could be of 
great interest to drug and pharmaceutical companies. Since there has been 
evidence that some of the endproducts of the oxidation of cholesterol could be toxic 
and that there are problems associated with expression of the gene for cholesterol 
oxidase in GRAS (Generally Regarded As Safe) hosts for the use in food systems, 
the study of sterol-reducing bacteria has re-emerged (Suzuki et al. , 1986; Bridigi et 
al. , 1993). 
Many species of sterol, steroid, and bile acid-reducing bacteria have been 
isolated and characterized, including Eubacterium, Clostridium, Lactobacillus, 
Mycobacterium, Bacillus, and Serratia (Samuelson, 1960; Arima et al., 1969; 
Marshcek et al., 1972; Essyen et al. , 1973; Essyen et al., 1974; Sadzikowski et al. , 
1977; Mott and Brinkley, 1979; Mott et al., 1980; White et al. , 1980; Brinkley et al. , 
1980; Brinkley et al., 1982; Macdonald et al., 1982; Gilliland et al. , 1985; Stanton, 
1987; Stanton and Cornell, 1987; Freier et al., 1994). 
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Genus Eubacterium 
Although , many sterol, steroid, and bile acid-reducing bacteria have been 
isolated and characterized, much of the more recent work has centered around 
isolates identified as the genus Eubacterium (Mott et al., 1980; Macdonald et al. , 
1982; White et al. , 1980; Feighner and Hylemon, 1980; Bokkenheuser et al. , 1980; 
Masuda and Oda, 1983; Glass and Burley, 1985; Watkins and Glass, 1991 ; Freier 
et al. , 1994). 
In context of this thesis, it should be noted that the genus Eubacterium 
should not be confused with the kingdom classification of the eubacteria, or "true" 
bacteria. Members of the genus Eubacterium are Gram-positive, non-sporing, 
chemoorganotrophic, obligately anaerobic rods (Moore and Moore, 1984). 
Species of Eubacterium produce mixtures of organic acids such as butyric, acetic, 
and formic, while growing at an optimal temperature of 37oc with a pH near 
neutrality (Moore and Moore, 1984; Brinkley et al. , 1982; Freier et al. , 1994). 
Eubacteria have been isolated from cavities of man and other animals, plant and 
animal products, infections of soft tissue, and soil (Mott et al. , 1980; Brinkley et al. , 
1982; Sadzikowski et al., 1977; Freier et al. , 1994; Moore and Moore, 1984; 
George and Falkler, 1992). Enumeration of the fecal material of baboons have 
shown counts of Eubacterium as high as 3.3 x 1010 per gram of dry fecal matter, 
which comprised around 16.7% of the total number of viable organisms recovered 
(Brinkley and Mott, 1978). Biochemically, members of the genus Eubacterium vary 
a great deal from overall morphology to growth substrates and culturing conditions 
(Moore and Moore, 1984; Brinkley et al. , 1982; Mott et al. , 1980). 
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Further interests in metabolic activities of species of Eubacterium were 
pursued when methylotrophic/acidogenic strains of Eubacterium limosum were 
isolated and characterized (Pacaud et al., 1986; Pacaud et al., 1985; Loubiere et 
al. , 1986; Genthner and Bryant, 1982). E. limosum cometabolizes methanol, along 
with carbon monoxide (CO) or carbon dioxide (C02) into acetic and butyric acids 
(Pacaud et al., 1985). Media were developed with initial levels of these acids to 
favorably produce one acid or the other in commercial acid production applications 
(Pacaud et al., 1986). 
These one-carbon substrates appear to enter a common metabolic pathway 
where they are incorporated into the acids produced by this fermentation . The 
common intermediate of the entry of methanol and C02 is the formation of acetyl-
coenzyme A (CoA) (Pacaud et al. , 1985). In the proposed model for methyltrophic 
growth by these strains of E. limosum, methanol is preferentially incorporated into 
the methyl group of acetyl CoA while the C02 is the precursor to the carboxyl group 
of the acids produced (Pacaud et al., 1985). The acetyl CoA produced enters into 
one of three following pathways: acetic acid production, butyric acid production , or 
biomass generation (Loubiere et al., 1986; Pacaud et al., 1985). The reactions 
yield reducing equivalents of nicotinamide adenine dinucleotide (NADH2) which 
appear to be balanced by the regeneration of NAO+ by the production of butyric 
acid (Pacaud et al. , 1985). 
The formation of acetyl CoA from the condensation of equimolar amounts of 
methanol and C02 has been proposed in a general assimilation model (Kerby et 
al. , 1983; Zeikus, 1983). Although the C02 is provided in the growth medium, the 
model proposes another source of C02 via methanol dissimilation which is thought 
to involve tetrahydrofolate (THF) intermediates (Pacaud et al., 1985). This results 
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not only in the production of NAD(P)H2 reducing equivalents, but also generation 
of additional ATP from the terminal steps of organic acid production via acetate and 
butyrate kinases (Zeikus, 1983). The excess NADH2 is thought to be recycled by 
two reverse-action dehydrogenases involved in the butyric acid biosynthetic 
pathway (Pacaud et al. , 1986). 
The amount of C02 present in the methylotrophic medium is the determining 
factor in the growth and nature of the organic acids produced (Loubiere et al. , 
1986; Pacaud et al., 1985; Pacaud et al. , 1986). The production of the organic acid 
overflow metabolites can be altered by adjusting the initial growth substrate 
concentrations of acetic and butyric acid (Pacaud et al. , 1985). The inclusion of 
acetate (50 mM) into the initial growth medium results in a homobutyric 
fermentation at improved rates of growth, and the added acetic acid is not 
metabolized during this fermentation (Pacaud et al. , 1986). 
Strains of E. limosum have also been grown with carbon monoxide (CO) as 
the sole carbon and energy source (Genthner and Bryant, 1982). Growth on CO or 
C02 supplemented with H2 resulted in normal growth of E. limosum at a pH 
optimum of 7.0-7.2 with a generation time of 7 hours (Genthner and Bryant, 1982). 
Bacterial growth was uninhibited in cultures with up to 50% CO and the CO was 
preferentially utilized before H2 utilization is significant (Genthner and Bryant, 
1982). 
Although much of the recent attention has centered around cholesterol-
reducing strains of Eubacterium, strains have been isolated which degrade and 
utilize a number of other commercially important sterols, steroids, and bile acids 
(Glass and Burley, 1985; Glass et al. , 1991; Watkins and Glass, 1991; White et al. , 
1980; White et al. , 1981 ; Masuda et al. , 1984; Bokkenhauser et al. , 1980; Feighner 
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et al. , 1979; Coleman et al. , 1987; Feighner and Hylemon, 1980). Some of the 
steroid, sterols, and bile acids which are reduced include: cholesterol , 
progesterone, 16-dehydroprogesterone, corticosterone, deoxycortisol , cholic acid, 
and chenodeoxycholic acid. 
Progesterone derivatives have been chemically reduced by strains of 
Eubacterium (Glass and Burley, 1985; Watkins and Glass, 1991). Cell 
suspensions of Eubacterium species strain 144 have been shown to quickly 
reduce 16-dehydroprogesterone to 17-isoprogesterone via a 16-
dehydroprogesterone reductase (16-DHPR) along with the provision of hemin or 
exogenous electron donors such as H2 or pyruvic acid (Glass and Burley, 1985). 
This strain also possessed additional steroid conversion activities, including the 
reduction of 64-65 double bond and the 3-keto group on the A ring of these steroids 
(Glass and Burley, 1985). These activities were not observed in the absence of 
electron donors and hemin, suggesting that a cytochrome-containing electron 
transport system may be involved in the flow of electrons from pyruvic acid or H2 to 
these enzymes which is consistent with strains of E. lentum when grown in hemin 
(Sperry and Wilkins, 1976; Glass and Burley, 1985). 
Several types of cytochromes have been identified in cell extracts of 
Eubacterium lentum (Sperry and Wilkins, 1976). E. lentum was shown to contain 
cytochromes a, b, and c along with an unidentified carbon monoxide binding 
pigment (Sperry and Wilkins, 1976). These cytochromes functioned only under 
anaerobic conditions and were rapidly reduced by dithionite, but not by ascorbate 
or reduced glutathione (Sperry and Wilkins, 1976). This was the first obligate 
anaerobe to be isolated which contained these three cytochromes (Sperry and 
Wilkins, 1976). 
16 
The enzyme which catalyzes the reduction of the 64-65 double bond in the A 
ring of 17a-progesterone was termed a Sa-steroid reductase (Glass et al., 1991 ). 
The Sa-reductase also required electron donors such as pyruvate, dithionite, and 
H2, resulting in the generation of reduced methyl viologen, which was essential for 
the reductase activity (Glass et al., 1991 ). NADH or NADPH, with or without flavin 
nucleotides did not serve as electron donors to the Sa-reductase (Glass et al. , 
1991 ). The similarity in the electron donor requirements for Sa-reductase and 16-
DHPR suggests a common electron transport mechanism which links pyruvic acid 
and H2 oxidation to steroid double bond reduction in Eubacterium strain 144 
(Glass et al., 1991 ). No activity was found when SB-steroids were assayed 
suggesting that no SB- to Sa-steroid isomerase was present (Glass et al., 1991 ). 
The 3-keto group of steroids was reduced by a 3a-hydroxysteroid 
dehydrogenase (3a-HSDH) in Eubacterium species strain 144 (Glass and Burley, 
198S). This NADP+-linked enzyme converts the 64-65 reduced steroid via the Sa-
steroid reductase to a pregnanolone derivative commonly isolated from rat fecal 
material (Glass et al. , 1991 ). The 3a-HSDH and Sa-steroid reductase activities 
were shown to be performed by separate enzymes and that 3a-HSDH activity was 
dependent upon the addition of oxidized NAO+ or NADP+ (Glass et al. , 1991 ). 
The Sa-reductase activity was localized to the membrane fraction and the 
enzyme was found to be solubilized by Triton X-100 (Glass et al., 1991 ). It has also 
been suggested that the genes for 16-DHPR and Sa-steroid reductase are 
differentially regulated (Glass et al., 1991 ). It was shown that 16-
dehydropregnanalone induced synthesis of 16-DHPR, but not Sa-reductase 
whereas, progesterone-induced cells contained Sa-reductase, but not 16-DHPR 
activity (Glass et al. , 1991). 
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Intestinal microflora have long been known to be involved in the conversion 
of many sterols and steroids within humans and animals. As a result, these 
bacteria play a significan~ role in the regulation of concentrations of particular 
steroids and sterols in the intestine and colon (Feighner et al., 1979). A strain of E. 
/entum has been shown to readily convert the substrates 11-deoxycorticosterone 
or corticosterone to progesterone via a 21-hydroxylase (Feighner et al., 1979; 
Feighner and Hylemon, 1980). Kinetics utilizing corticosterone yielded an 
apparent KM of 7.35 µM and a Vmax of 15.4 nmol (Feighner and Hylemon, 1980). 
The dehydroxylase activity was optimized when reduced pyridine nucleotides and 
an oxidized flavin coenzyme (FMN or FAD oxidoreductase) were added to reaction 
mixtures (Feighner et al. , 1979). The resulting NAD(P)H: flavin oxidoreductase 
activity was spectrophotometrically measured (Feighner et al., 1979). 
Some strains of E. lentum which undergo 21-dehydroxylation of steroid 
hormones also have been shown to perform a 3a-hydroxysteroid dehydrogenase 
activity as described in other strains of Eubacterium (Feighner et al., 1979; Glass et 
al., 1991 ). The physiological and metabolic significance of the dehydroxylation of 
steroids by these intestinal anaerobes is unknown. However, these non-
assimilating steroid transformations might serve to determine routes of excretion of 
neutral steroid hormones (Feighner and Hylemon, 1980). The steroids themselves 
might serve as terminal electron acceptors since they have been shown not to 
stimulate growth (Feighner et al. , 1979; Feighner and Hylemon, 1980). 
The most well-known and characterized enzymatic activity of strains of 
Eubacterium is the bile-acid 7a-dehydroxylase, or 7a-hydroxysteroid 
dehydrogenase (White et al. , 1980; White et al. , 1981; Macdonald et al., 1982; 
Masuda et al., 1983; Masuda and Oda, 1983; Masuda et al., 1984; Coleman et al., 
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1987; Coleman et al. , 1987; Coleman et al. , 1988; Franklund et al. , 1990). 
Members of Eubacterium, as well as many other intestinal microorganisms modify 
taurine and glycine derivatives of primary bile acids via this enzyme (Franklund, et 
al., 1990). 
Purification of the constitutively expressed 7a-hydroxysteroid 
dehydrogenase (7a-HSDH) resulted in the isolation of a protein with a subunit 
molecular mass of 27 kDa (Franklund et al. , 1990). Gel filtration utilizing 
Sepharose CL-68 yielded a native molecular mass of about 124 kDa, suggesting 
that the enzyme exists as a tetramer of four identical subunits (Franklund et al. , 
1990). As in the cholesterol oxidase system, 7a-HSDH activity was inhibited by 
sulfhydrl inhibitors, while the addition of metal chelators had no effect upon 
catalytic activity (Franklund et al., 1990; Uwajima et al. , 1973). The enzyme also 
demonstrated a great range of substrate specificity with the ability of the enzyme to 
utilize a number of bile acids and bile acid analogs (Falklund et al. , 1990). 
It has been shown that 7a-HSDH follows Michaelis-Menten kinetic models 
(White et al. , 1980; White et al., 1981; Franklund et al., 1990). Substrate saturation 
kinetics plots showed that most bile acid substrates demonstrated KM values 
between 4 and 20 µM, while the Vmax range was from 601-674 µmol/min·mg 
protein (White et al. , 1981; Franklund et al. , 1990). The kinetic plots along with 
substrate inhibition products demonstrated an ordered, sequential direction of bile 
acid oxidation and reduction with NAD(P)H binding first (Franklund et al., 1990). 
The N-terminal amino acid sequence of purified enzyme revealed homology to 
several short, non-zinc alcohol/polyol dehydrogenases, and a possible bile acid 
binding domain (Franklund et al., 1990). 
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Genes for 7a-HSDH were cloned into Escherichia coli (Coleman et al., 
1987). Transformants containing the 2.2-kb fragment encoding the 27 kDa 
structural gene product for 7a-HSDH showed activity with the addition of cholic 
acid (Coleman et al., 1987). However, it appears that cholic acid does not play a 
role in the regulation of expression of the catalytic peptide in Escherichia coli 
(Coleman et al., 1987). The synthesized peptide from transformed cells showed 
cross reactivity with antibodies which were raised from the purified 7a-HSDH from 
Eubacterium (Coleman et al., 1987). 
The expressed protein was shown to have sequence homology to a number 
of other bacterial alcohol-polyol dehydrogenases which contain pyridine 
nucleotide binding domains (Coleman et al., 1988). This gene represents the first 
cloned gene from a species of Eubacterium (Coleman et al. , 1987). 
Cholesterol-Reducing Eubacterium Species 
Interest in bacteria which chemical ly reduce cholesterol evolved in response 
to a need for the understanding of the processes involved in the regulation of levels 
of dietary cholesterol in humans. Recently, cholesterol-reducing bacteria have 
been again studied in the light of current research of the cholesterol oxidase 
system. Since there has been evidence that some of the endproducts of the 
oxidation of cholesterol could be toxic and problems associated with expression of 
the gene for cholesterol oxidase in GRAS hosts for use in food systems, the study 
of cholesterol-reducing bacteria has re-emerged (Suzuki et al. , 1986; Dehal et al. , 
1991 ; Bridigi et al., 1993). 
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The isolation of bacteria that chemically reduce cholesterol has been of 
interest due to research that indicated that many fecal neutral sterols are derived 
from dietary origins rather than biliary or intestinal wall sources (Wilson and 
Reinke, 1968). It has been found that during digestive activities within the intestine, 
cholesterol is converted to two bacterial conversion products, coprostanol and 
coprostanone (McNamara et al., 1981 ). Cholesterol, coprostanol, and 
coprostanone together account for over 95% of the neutral steroid content of feces 
with the remainder being primarily cholestanol. It has been shown that up to 50% 
of the fecal sterols, depending upon diet, are present in the form of coprostanol 
(Heftman, 1970). 
The isolation of bacteria that chemically reduce cholesterol has focused 
upon those bacteria which convert cholesterol to coprostanol. Coprostanol , the 5B-
hydrogenated product of the reduction of cholesterol by these bacteria, has been 
shown to be poorly absorbed within the human gastrointestinal tract 
(Bhattacharyya, 1986). Until the advent of improved isolation techniques for these 
bacteria, a body of earlier work was done with cecal contents and fecal material 
from animals and humans where rates of conversion of cholesterol to coprostanol 
were detected and quantitated (Dam, 1934; Rosenfeld et al. , 1954; Snog-Kjaer et 
al. , 1956; Rosenfeld and Gallagher, 1964; Bjorkhem and Gustafsson, 1971 ; 
Bjorkhem et al. , 1973; Wilkins and Hackman, 1974; Ashes et al. , 1978). 
Several species of bacteria that chemically reduce cholesterol have been 
isolated and characterized, including species of Eubacterium, C/ostridium, 
Lactobacil/us, Mycobacterium, Bacillus, and Serratia (Arima et al. , 1969; Marshcek 
et al., 1972; Essyen et al., 1973; Essyen et al. , 1974; Sadzikowski et al. , 1977; Mott 
and Brinkley, 1979; Mott et al., 1980; Brinkley et al. , 1980; Brinkley et al. , 1982; 
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Gilliland, et al., 1985; Stanton, 1987; Stanton and Cornell, 1987; Freier et al. , 
1994). Although , many bacteria that chemically reduce cholesterol have been 
isolated and characterized, much of the more recent work has centered around 
isolates identified as the genus Eubacterium (Mott et al. , 1980; Brinkley et al. , 
1982, Dehal et al. , 1991 ; Freier, 1991 ; Lulich et al. , 1994; Freier et al., 1994; Lulich 
et al., 1995). 
Initial studies on biological cholesterol reduction were performed in vitro 
with human feces or colon contents (Dam, 1934). The cholesterol added to the 
fecal material was shown to be hydrogenated into coprostanol; however, the 
organism(s) responsible were not isolated (Rosenfeld et al. , 1943). The rate of 
hydrogenation occurred at rates as high as 80% in vitro, and it was shown that the 
common intestinal microflora were not responsible for the hydrogenation of 
cholesterol to coprostanol (Snog-Kjaer et al., 1956). 
The enzyme responsible for the reduction of cholesterol to coprostanol has 
been named a "cholesterol reductase" (Dehal et al. , 1991 ; Freier et al., 1994). The 
proposed mechanism involves the reduction of the fl5-fl6 bond of ring B resulting in 
the A/B ring structure having a cis configuration (Bjorkhem and Gustafsson, 1971; 
Margalith , 1986)(Figure 1 ). As a result of the configuration change, the C-3 
hydroxyl group is in an equatorial position (Bjorkhem and Gustafsson, 1971 ). The 
combination of an equatorial hydroxyl group, coupled with the cis ring 
configuration is thought to be the main reason for the poor uptake of coprostanol by 
animals (Bhattacharyya, 1986). The Sa-hydrogenated derivative cholestanol, as 
well as cholesterol , have trans ring junctions with the hydroxyl group in the axial 
position resulting in better uptake by the intestine (Bhattacharyya, 1986). 
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Two mechanisms for the bacterial biotransformation of cholesterol to 
coprostanol by have been proposed (Figure 1 ). One is the direct reduction of the 
65-66 double bond of cholesterol to yield coprostanol (Rosenfeld et al., 1954; 
Rosenfeld and Gallagher, 1964). The other mechanism involves the indirect 
reduction of cholesterol via three intermediates: 5-cholesten-3-one, 4-cholesten-3-
one, and coprostan-3-one (Bjorkhem and Gustafsson, 1971 ; Bjorkhem et al., 1973; 
Ren, 1991 ). The intermediates 4-cholesten-3-one and coprostan-3-one have been 
identified, but 5-cholesten-3-one has yet to be identified in the indirect reduction of 
cholesterol (Bjorkhem, et al., 1973; Ren , 1991 ). It is thought that the possible 
isomerization of the 65-66 double bond to the 64-65 position is the rate-limiting step 
in the indirect reduction of cholesterol to coprostanol (Bjorkhem et al. , 1973). Due 
to the high rate of this isomerization, 5-cholesten-3-one may only briefly exist as a 
transient intermediate, thus providing an explanation for the inability to detect it by 
current methods (Bjorkhem et al. , 1973; Ren, 1991 ). 
The exact mechanism of the bacterial reduction of cholesterol to coprostanol 
by these strains of Eubacterium is largely unknown. Since early work was 
performed with rat cecal contents, a possibility might be that both mechanisms of 
cholesterol reduction are occurring simultaneously due to the complex mixture of 
the bacteria used. The current mechanism supports the possibility of both 
mechanisms occurring simultaneously in the bacterial conversion of cholesterol to 
coprostanol (Bjorkhem et al. , 1973; Ren, 1991 ). Detergent extracts of cecal 
contents used in radio-labeled studies of chemical cholesterol reduction were 
unsucessful due to the inability to recover fractions containing cholesterol reduction 
activity (Bjorhem et al., 1973). 
HO 
HO 
Figure 1. 
Choles ter o l 
H 
Coprosta no l 
23 
A AH 2 
\,, /..,,. 
C holes t-5-en -3-one 
lromoriu•;oo i 
C hol es t-4-en -3-one 
AHA 
A 
H 
Copros t a n-3-one 
Proposed reaction mechanisms of cholesterol 
reduction by E. coprostanoligenes (Bjorkhem 
et al. , 1973) 
24 
Purification of cholesterol reductase from fecal material was attempted by 
ion-exchange and gel filtration chromatography (Bjorkhem et al. , 1973). Enzyme 
activity which was NADH-dependent, was observed in crude soluble fractions, but 
was quickly lost upon further purification. 
The use of ion-exchange chromatography was unsuccessful due to the 
apparent !ability of the enzyme as indicated by an almost 70% loss of activity in 
crude supernate samples stored at 4°C for up to 48 hours (Bjorkhem et al., 1973). 
There have been many strains of the genus Eubacterium isolated which 
chemically reduce cholesterol to coprostanol (Ashes et al. , 1978; Brinkley et al. , 
1982; Mott et al., 1980; Sadzikowski et al., 1977; Freier et al., 1994). Many of the 
strains of Eubacterium isolated required either homogenized brain or lipid extracts 
of brain for growth and long-term maintenance (Brinkley et al. , 1980; Mott and 
Brinkley, 1979). Many of the strains isolated also required large amounts of 
cholesterol for growth and a great many of the isolates grew very poorly, or not at 
all , on solid growth medium (Mott and Brinkley, 1979; Brinkley et al. , 1980; Freier, 
1991; Lulich et al., 1994). Isolates which did plate on solid media yielded colonies 
which were extremely small (0.05-0.Smm) in diameter, and plating efficiencies 
were extremely low (Brinkley et al., 1980; Sadzikowski et al., 1977; Mott et al., 
1979; Essyen et al. , 1973; Lulich et al. , 1994). Direct assays of cholesterol 
reductase activity were very difficult due to the heterogeneity of growth media; 
however, in vitro studies showed that up to 90% of the cholesterol present in the 
growth medium was reduced to coprostanol (Brinkley et al. , 1980; Freier et al. , 
1994). The high apparent rates of cholesterol reduction by these bacteria that 
chemically reduce cholesterol showed promise of a new and potentially safer way 
to reduce levels of dietary cholesterol in humans. 
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As previously mentioned, many of the cholesterol-reducing isolates of 
Eubacterium were difficult to culture and when culturable, difficult to work with due 
to the high amount of lipids and cholesterol present in the growth medium (lulich, 
et al., 1994). As a result, cholesterol-reducing strains with better growth 
characteristics were sought which would facilitate better biochemical studies of the 
cholesterol reductase. An isolate from a hog sewage lagoon, named Eubacterium 
coprostanoligenes, showed several unique properties making this isolate more 
amenable to biochemical and genetic studies of cholesterol reduction by the 
cholesterol reductase (Freier, 1991; Freier et al., 1994). 
E. coprostanoligenes is unique, compared to other cholesterol-reducing 
eubacteria in that it does not require brain , lipid extracts of brain, or 
plasmenylethanolamine for growth and long-term maintenance (Freier, 1991 ; 
Freier et al., 1994). However, E. coprostanoligenes does require lecithin for 
growth (Freier, 1991 ). The significance of lecithin as a growth requirement is 
currently unknown (Freier et al. , 1994). Another unique aspect is that, as opposed 
to previously isolated strains of eubacteria that chemically reduce cholesterol , E. 
coprostanoligenes grew in the absence of large amounts of cholesterol or other 
related sterols (Freier et al. , 1994; Lulich et al. , 1994). 
E. coprostanoligenes provided an isolate that was easier to work with and 
quickly reduced cholesterol to coprostanol. In actively growing cultures of E. 
coprostanoligenes, the concentration of cholesterol in the growth medium was 
lowered from 2.0 mg/ml to less than 0.003 mg/ml over a three-day incubation 
period, which was significantly lower than previously isolated bacteria that 
chemically reduced cholesterol (lulich et al. , 1994). This strain has shown promise 
in that it can theoretically decrease the concentration of cholesterol to levels 10-to 
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100-fold lower than those found in meat and dairy products (Bechtel, 1986; Price 
and Schweigert, 1987). 
E. coprostanoligenes was shown to metabolize pyruvic acid, and this 
metabolism has been postulated to be related to the chemical cholesterol reduction 
where pyruvic acid serves as either an electron donor or cofactor in the reduction of 
cholesterol to coprostanol (Freier et al., 1994). This postulation is supported by 
other work which showed that pyruvic acid acts as an electron donor for the 16-
dehydroprogesterone reductase in cell extracts of Eubacterium sp. strain 144 
(Glass and Burley, 1985; Watkins and Glass, 1991 ; Freier et al., 1994). 
Since coprostanol is not absorbed by the human gastrointestinal tract, there 
exists potential use for cholesterol reductase in the reduction of dietary cholesterol. 
New technologies for lowering levels of cholesterol utilizing cholesterol reductase 
are being developed (Dehal et al. , 1991 ). Cholesterol reductase also shows 
promise in that the potential rates of reduction could result in significantly lower 
levels of cholesterol in foods and hypercholesteremic patients. More promise 
exists in that no toxic endproducts are produced in the reduction of cholesterol and 
further characterization and purification of cholesterol reductase shows great 
commercial promise. 
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IMPROVED CULTURE MEDIUM AND KINETIC STUDIES OF STEROL 
REDUCTION BY 
Abstract 
Eubacterium coprostanoligenes 
A paper to be submitted for publication to 
Anaerobe 
Ronald G. Lulich and A.A. DiSpirito 
Eubacterium coprostanoligenes is a Gram-positive, obligately anaerobic 
bacterium isolated from a swine lagoon on the basis of chemical cholesterol 
reduction . Biochemical studies on the cholesterol reductase system in E. 
coprostanoligenes have been hampered by poor growth yields and the production 
of a capsule in the isolation medium. To overcome these problems, the standard 
culture medium was modified to increase cell yields and reduce the production of 
extracellular capsular polymers. First, the cholesterol reductase system was 
determined to be constitutive , and elimination of cholesterol and lactose from the 
growth medium drastically reduced capsular polymer formation. Second, 
increased levels of lecithin in the growth medium reduced the level of capsular 
formation further and also increased the cell yield four-fold. 
E. coprostanoligenes was also grown in a modified, lecithin-free 
methylotrophic medium. Growth rates were comparable to those observed in the 
original isolation medium; however, growth of E. coprostanoligenes in this 
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methylotrophic medium occurred in the absence of lecithin. Cells grown in the new 
culture medium also showed higher rates of chemical cholesterol reduction. 
Kinet ic studies indicate that the rate limiting step in whole cell , chemical 
cholesterol reduction was substrate accessibility. Cholesterol availability was 
increased using lecithin/cholesterol micelles, which resulted in a 20-fold increase 
in the rate of cholesterol reduction. The rate of cholesterol reduction in the new 
assay system showed an apparent Vmax of 2.9 µmol/min·mg cell protein and an 
apparent KM of 111 µM. From this whole-cell assay, a cell-free assay was 
developed using ascorbate as a reductant. 
The cholesterol reductase activity demonstrated a broad substrate 
specificity. Cholesterol, 4-Cholesten-3-one, coprostanone, corticosterone, 17-
Hydroxyprogesterone, anhydroxyprogesterone, and progesterone demonstrated 
comparable KM app and V max appvalues of reduction. Mixed substrate studies with 
cholesterol, 4-Cholesten-3-one, coprostan-3-one, and progesterone indicate a 
competitive type of inhibition. Coprostan-3-one or 4-cholesten-3-one, proposed 
intermediates in a bacterial multiple step reduction of cholesterol showed a 
competitive type of inhibtion. 
Introduction 
Consumer demand for reduced-cholesterol foods has stimulated research in 
the development of physical , chemical, and biological technologies to decrease the 
amounts of cholesterol and triacylglycerols in foods (Arima et al. , 1969; Bjorkhem et 
al. , 1973; Dehal et al. , 1991 ; Johnson and Somkuti , 1990; Marschek et al., 1972; 
Mazschner and Fine, 1989). Of the three, biological methods are often preferred, 
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since they are often less harsh, form fewer by-products, and are considered 
"natural" by the consumer. Much of the research in decreasing cholesterol content 
of foods biologically has focused on the cholesterol oxidase system. The 
microorganisms catalyzing this reaction often completely oxidize cholesterol to 
carbon dioxide and water (Turfitt, 1946; Noma and Nakayama, 1976; Smith and 
Brooks, 1976; Ferreira and Tracey, 1984; Smith et al. , 1993). The enzyme 
responsible for the init ial oxidation, cholesterol oxidoreductase, catalyzes the 
oxidation of cholesterol to 4-cholesten-3-one via the intermediate 5-cholesten-3-
one (Noma and Nakayama, 1976; Molnar et al., 1993; Uwajima et al. , 1974; Smith 
and Brooks, 1977; Turfitt, 1948; Stadtman et al. , 1954; Richmond, 1973). 
Identification of bacteria that chemically convert cholesterol to coprostanol 
has provided a second enzyme system to decrease cholesterol content in foods. 
Coprostanol, the hydrogenated product of this chemical reduction, is poorly 
absorbed by humans as well as in several test animals (Dam, 1934; Ashes et al. , 
1978; Bjorkhem and Gustafasson, 1971; Rosenfeld et al., 1954; Rosenfeld et al. , 
1963; Rosenfeld and Gallagher, 1964; Snog-Kjaer et al. , 1956; Bhattacharyya, 
1986). Several strains of intestinal bacteria have been shown to catalyze this 
reduction, the most common being different species of the genus Eubacterium. 
Members of the genus Eubacterium are Gram-positive, chemoorganotrophic, 
nonspore forming, obligately anaerobic rods (Ashes et al. , 1978; Brinkley et al. , 
1982; Eyssen et al. , 1973; Mott and Brinkley, 1979; Sadzikowski et al., 1977; Freier 
et al. , 1994). 
Two mechanisms of bacterial reduction of cholesterol to coprostanol have 
been proposed (Fig. 1 ). One is the direct reduction of the b,5,6_double bond of 
cholesterol to coprostanol (Bjorkhem et al. , 1973; Bjorkhem and Gustafasson, 
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1971; Rosenfeld and Gallagher, 1964). The other proposed mechanism involves a 
multi-step reduction . Cholesterol is first oxidized to 5-cholesten-3-one, followed by 
an isomerization to 4-cholesten-3-one, a reduction to coprostan-3-one, followed by 
a second reduction to coprostanol (Bjorkhem et al., 1973; Bjorkhem and 
Gustafasson, 1971 ; Ren , 1991 ). 
The physiological function of chemical cholesterol reduction has not been 
identified (Mott and Brinkley, 1979; Sadzikowski et al., 1977; Freier et al., 1994). 
The poor growth characteristics of Eubacterium sp. have hampered studies on this 
enzyme system. Most strains of cholesterol-reducing Eubacterium required either 
homogenized brain tissue, lipid extracts of brain, or plasmenylethanolamine for 
long-term maintenance (Mott and Brinkley, 1979). Many also required cholesterol 
or a related sterol for growth (Mott and Brinkley, 1979; Sadzikowski et al. , 1977). 
An isolate from a hog lagoon, Eubacterium coprostanoligenes, showed several 
unique properties that made the isolate more amenable to biochemical and genetic 
studies (Freier, 1991 ). First, this strain did not require plasmalogen or mammalian 
brain tissue extracts, making the medium less viscous than previous cholesterol-
reducing Eubacterium media. Second, in actively growing cultures, E. 
coprostanoligenes showed higher affinity for cholesterol and higher reduction 
rates than the other cholesterol-reducing strains tested . The high rates and high 
affinities of the cholesterol reductase system in E. coprostanoligenes makes this 
bacterium an ideal test system to examine the potential use of cholesterol-reducing 
bacteria in food production processes. 
Although an improvement over other cholesterol-reducing bacteria, the 
growth characteristics of E. coprostanoligenes were still too poor to attempt 
biochemical or genetic studies. In addition to long generation times (approximately 
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3.5 hours) and low yields (150 - 200 µg cell protein per ml culture medium) , E. 
coprostanoligenes produces a large capsule when grown on either isolation 
medium (Lulich et al., 1994). This capsular material has made whole cell and cell-
free assays very difficult because the lipids in the medium are concentrated in the 
capsular material. The high lipid content associated with the capsular material has 
made harvesting cells difficult, and the membrane fraction associates with the 
capsular fraction upon cell lysis, making membrane isolations difficult. 
This paper describes two new growth media that significantly improve yields 
and decrease concentration of extracellular polysaccharides. These media have 
made physiological and biochemical studies on the cholesterol reductase system 
in E. coprostanoligenes possible. Cells from these media were used to examine 
the specificity and kinetics of cholesterol reduction . 
Materials and Methods 
Strains and growth conditions 
Eubacterium coprostanoligenes (ATCC #51222) was cultured by modified 
serum bottle "Hungate" techniques (Freier et al., 1994; Miller and Wolin , 1974). 
The media used in these experiments were prepared as follows: Basal cholesterol 
(BC) medium was prepared as previously described (Freier, 1991 ). The medium 
was reduced by boiling and was dispensed anaerobically in 90-ml aliquots into 
125-ml Hypo-vials (Pierce Chemical, Rockford, IL.) which were subsequently 
sealed with butyl rubber stoppers and autoclaved. The final pH upon cooling was 
7.2. Inoculations were performed in an anaerobe chamber utilizing a 10% 
inoculum, and cultures were incubated at 37oc for 5-7 days. 
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Eubacterium (EM) medium was prepared as above with the following 
changes: no cholesterol, 0.075% lecithin, no lactose, and 0.1 % pyruvic acid. 
Inoculations were performed in the same manner as described above. For batches 
above 3 liters, transfers were performed anaerobically with Masterflex pumps and 
oxygen-impermeable Tygon tubing lines run from each carboy with vents adapted 
to the anaerobic chamber (Cole-Parmer, Inc. Chicago) (Norton Industries) (Lulich 
et al. , 1994). 
Methylotrophic medium (MSM) for the growth of E. coprostanoligenes on 
methanol and C02/CO was prepared as previously described with the following 
modifications (0.5 L formulation) (Pacaud et al., 1986; Pacaud et al. , 1986; 
Loubiere et al., 1986; Sharak Genthner and Bryant, 1982; Lidstrom, 1988): 
Solution A: 5 ml Whittenbury's Trace Elements (Whittenbury et al., 1970), 0.25 g 
NH4CI, 4 mM sodium thioglycolate, 0.005 g NaMo04 , 4 µM resazurin , 5 µM CuS04 , 
0.25 g casitone, 0.25 g yeast extract, and 0.7 mM CaCl2 (all anhydrous) . Part A 
was reduced by boiling , cooled under oxygen-free N2, and transferred to an 
anaerobic chamber where 80-ml aliquots were dispensed into 125-ml hypovials, 
sealed, and sterilized. 
To 80-ml aliquots of Solution A, the following were aseptically added under 
anaerobic conditions: 1.25 ml 1 M sodium acetate, 7.5 ml 1 M methanol , 1 ml 0.5 M 
Na/KP04 buffer (pH 7.2) , and 25 µI Staley's vitamin solution. Upon inoculation, vial 
atmospheres were sparged with approximately 5 psi CO or C02 prior to incubation. 
Cultures were incubated at 37°C for 3-5 days and transferred five consecutive 
times within the test medium prior to assaying for cell yield and cholesterol 
reductase activity. 
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Isolation of cells, soluble and membrane fractions 
Cells were harvested by centrifugation 10,000 x g for 20 minutes at 4°C and 
washed in degassed 10 mM sodium/potassium phosphate, 4 mM sodium 
thioglycolate buffer, pH 7.2 (reducing buffer) and immediately placed into Hypo-
vials under anaerobic conditions . Vials containing whole cells were incubated at 
37oc when used in whole cell assays or put on ice in preparation for lysis. Cells 
were lysed by passage through a French pressure cell (Aminco Instruments, Inc.) 
three times at 18,000 psi (piston diameter = 1 inch); anaerobic conditions were 
maintained by flushing with oxygen-free nitrogen when the cell was opened . A 
canula with nitrogen was also utilized to stream nitrogen into the collection vial 
during lysis. The mixture was then centrifuged at 10,000 x g for 20 minutes at 4°C 
to remove unlysed cells and debris. The supernate (cell-free fraction) was placed 
in Hypovials and stored under nitrogen until utilized for assays or fractionation 
studies. In cell fractionation studies the supernate was centrifuged at 150,000 x g 
for 90 minutes at 4°C. The pellet from this preparation was used as the membrane 
fraction , and the supernate was used as the soluble fraction. 
Quantitation of extracellular polysaccharides 
E. coprostanoligenes was grown to log phase. 1.5-ml aliquots from each 
culture were dispensed in microfuge tubes and sonicated for 20 seconds at 26 W 
with a Braun-sonic 15 sonicator (R Braun, Melsungen, AG) . Sonicated cells were 
then centrifuged at 13,200 x g for 20 minutes at 4°C The supernates (1 ml) were 
assayed for total extracellular polysaccharides by the phenol/sulfuric reaction 
utilizing glucose as a standard (Hanson and Phillips, 1981 ; Powell et al. , 1982). 
Escherichia coli strain K-12 was used as a control. 
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Preparation of cholesterol/lecithin mixtures 
Blended cholesterol /lecithin was prepared by suspending a 1 :2 molar ratio 
of cholesterol/soy lecithin (lecithin-97% phosphatidyl choline; Calbiochem, La 
Jolla, CA.) in assay buffer. The mixture was homogenized in a Waring blender for 
15 minutes under a stream of nitrogen. The homogenate was placed into vials and 
put under anaerobic conditions. 
Cholesterol/lecithin mixed micelles were prepared at described by Luk et al. 
(1993) using a 1 :2 molar ratio of cholesterol:lecithin and maintaining anaerobic 
conditions as much as possible. Micelles were added to reaction mixtures to give a 
final cholesterol concentration of 0.5 mM (0.2 mg/ml) as determined by gas 
chromatography. 
Protein determination 
Protein concentrations were determined by Folin phenol method as 
described by Lowry et al. (1951 )using bovine serum albumin as the standard. 
Sterol and steroid reduction quantitation assay 
Sterol and steroid reduction assays were performed in sealed Hypovials at 
37°C under anaerobic conditions. All sterols and steroids used as experimental 
substrates were obtained from Steraloids (Wilton, NH) . Experimental substrates 
were prepared in lecithin to form micelles as previously described (Luk et al. , 
1993). The reaction mixtures contained per 0.5 ml washed cells: 2.0-2.5 mg 
protein; 0.005 mM, 0.1 mM, 0.05 mM, 0.075 mM, 0.1 O mM, or 0.5 mM sterol or 
steroid ; pyruvic acid, 10 mM; CaCl2, 50 mM. Assay buffer (10 mM 
35 
sodium/potassium phosphate buffer, pH 7.2) was added to bring the total volume to 
0.5 ml, and the vials were pre-incubated at 37°C for 1 hr prior to assay. 
To pre-incubated vials, 0.5 ml of cells or cell-fractions were anaerobically 
injected into the sealed vials. The vials were incubated at 37oc for 1 hour. 
Following incubation, the reaction mixtures were extracted with 
methanol/chloroform/water as described by Bligh et al. (Bligh and Oyer, 1959). 
Extracted organic phases were dried down under nitrogen to completeness. The 
dried extracts were derivatized with a 1: 1 ratio of N-0-bis (trimethylsilyl) 
Trifluoroacetamide with 1 % Trimethylchlorosilane (BSTFA in 1 % TMCS) (Pierce, 
Rockford, IL) and acetonitrile. 
Derivatized mixtures were sealed and heated at 65°C for 1 hr prior to 
injection. Detection of steroids and sterols was determined by gas chromatography 
with an Autosystems gas chromatograph (Perkin-Elmer, Norwalk, CT) equipped 
with a flame ionization detector. Analysis column was a 1/8", 0.91 m glass column 
packed with SP-2250 on 100/ 120 Supelcoport (Supelco, Inc. Bellafonte, PA). 
Running conditions were as follows: Oven, 25ooc ; injector, 29ooc; detector, 
325°C; carrier gas flow rate, 20 ml/min. 
Cell-free assay 
Potential reductants were screened in the following concentrations: 
pyruvate, 10 mM; succinate, 10 mM; reduced nicotinamide adenine dinucleotide 
(NADH), 2 mM; lumiflavin + EDTA, 20 µM; dithionite, 2 mM; ascorbate, 2 mM ; 
sodium thioglycolate, 5 mM. Some of the reductants were screened in tandem with 
the following redox dyes: methyl viologen, 5 mM; benzyl viologen, 5 mM. Sodium 
ascorbate + N,N,N ', N'-tetramethyl-p-phenylene diamine hydrochloride (TMPO) was 
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prepared as outlined by Ferguson-Miller et al. (1976). Ascorbate, methyl and 
benzyl viologen , reduced NADH, and ascorbate!TMPD were prepared fresh in 
amber vials. Lumiflavin was prepared as described by DiSpirito et al. (1987) and 
photoreduced in reaction vials with a 120 watt flood lamp with a water filter 
between reaction vials and light source for 10-20 minutes prior to assaying. All 
redox dyes along with ascorbate, reduced NADH, and dithionite were prepared 
fresh and added just before initiation of reactions. 
Vials were pre-prepared with a total volume of 1 ml. To the vials, the 
following were added under anaerobic conditions: cholesterol/lecithin micelles, 
0.5 mM; lecithin stock solution (as described above) , 40 µI; CaCl2, 5 mM; and 
assay buffer (pH 7.2) added to bring the total volume to 0.5 ml. Reductants and/or 
redox dyes were added right before assay and vials were pre-incubated at 37oc 
for 50-60 minutes before the addition of crude lysate. When specified, H2 gas was 
added to atmospheres of vials to a total concentration of 50% along with reduced 
nitrogen. All other vials contained 100% nitrogen. The reductants, redox dyes, and 
cell lysate were added to reaction vials with Hamilton gas-tight syringes (Hamilton, 
Reno, NV.) which were purged with N2 before drawing. 
Steroid/sterol kinetics 
Kinetic studies were carried out with 6-7 day washed whole-cell cultures of 
E. coprostanoligenes. All sterols and steroids were obtained form Steraloids 
(Wilton, NH) and checked for purity prior to use. From preliminary compatibility 
studies, the following steroids and sterols were chosen: cholesterol , 4-Cholesten-
3-one, coprostan-3-one, corticosterone, and progesterone. Reaction vials were 
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prepared as previously described for the other whole cell assays, and all assays 
were pertormed under anaerobic conditions. 
Kinetic studies of chosen sterols and steroids were carried out utilizing 
micellar solutions of steroid/sterol with lecithin. These micellar solutions were 
prepared as previously described for whole cell and cell-free studies in this paper. 
Reactions were incubated for 1 hour and upon completion , were extracted, 
derivatized, and assayed for reduction activity as already described in this paper. 
Results 
Culture medium 
All of the components in the growth media described by Freier et al. (1994) 
were determined to be in excess except lecithin. Optimal growth of E. 
coprostanoligenes was obtained with the removal of lactose and cholesterol and 
increasing the lecithin concentration to 2.0 mg/ml (Table 1 ). Levels of lecithin in 
excess of 2.2 mg/ml appeared to be toxic to E. coprostanoligenes. There was no 
difference in total cell yields in EM medium with cholesterol versus EM without 
cholesterol (Table 1 ). The lecithin-optimized EM medium resulted in almost a 4-fold 
increase in cell yields versus the original isolation medium (BC) (Table 1 ). 
Growth of E. coprostanoligenes in defined minimal salts medium 
The growth of E. coprostanoligenes in lecithin-free minimal salts medium 
was successful (Table 1 ). Highest yields were obtained when E. 
coprostanoligenes was grown in MSM with CO added as the main atmospheric 
gas (Table 1 ). Previous characterization of E. coprostano/igenes stated an 
absolute requirement for lecithin in the growth medium. Cells harvested from MSM 
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Table 1. Growth yields and cholesterol reductase activity of E. 
coprostanoligenes as grown in modified EM, BC, and 
MM media. 
Cholesterol Rate of Intermediate Formation 
Yield Reductase {emol/min·mg erotein} 
( µ g Activity (pmol 
protein/ coprostanol/ 4 -Cholesten -3- Coprostan-3-
Medium ml min·mg ~rotein one one 
BC 390 409 ND* ND 
BC-No 
Cholesterol 407 421 ND ND 
EM 975 1007 235 ND 
EM-No 
Cholesterol 943 996 262 ND 
EM-2.0 mg/ml 
Lecithin 1474 1566 405 128 
EM-2.0 mg/ml 
Lecithin-No 1456 1534 422 117 
Cholesterol 
MSM w/o 
Acetate+ 884 355 ND ND 
Lecithin+C02 
MSM w/o 
Acetate+C02 985 385 ND ND 
MSM+Lecithin 
+C02 867 381 ND ND 
MSM w/o 
Acetate+ CO 1031 6 10 105 ND 
MSM+C02 922 385 ND ND 
MSM+CO 11 52 669 116 ND 
MSM+Lecithin 
+CO 11 69 672 123 ND 
*ND= Not Detected 
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demonstrated cholesterol reductase activity. However, growth was similar with or 
without lecithin. 
When E. coprostanoligenes was grown in MSM medium with CO, cell yields 
were comparable to previously developed isolation media were observed (Table 
1 ). However, cholesterol reductase activity was somewhat lower than had been 
observed from cells grown in EM medium (Table 1 ). The cholesterol reductase 
activity of cells grown in MSM was highest under CO. The presence of lecithin in 
the growth medium did not significantly affect the rate of cholesterol reductase 
activity. When E. coprostanoligenes was grown in MM with C02 in the presence or 
absence of lecithin, rates of cholesterol reductase activity were almost 40%-45% 
lower than with washed whole cells grown in the same medium under a CO 
atmosphere (Table 1 ). 
EM, BC, and MSM media were prepared in agar form as well. There was no 
improvement in colony size or plating efficiency when E. coprostanoligenes was 
grown on EM , BC, or MSM agar plates. Colonies were about 0.5 mm in diameter, 
taking 5-7 days to appear, which was consistent in previous plating attempts of E. 
coprostanoligenes (Freier, 1991; Freier et al. , 1994, Lulich and DiSpirito, 1994). 
Reduction of extracellular polysaccharides 
In addition to lowering cell yields, lactose and cholesterol were associated 
with the production of extracellular polysaccharides by E. coprostanoligenes. 
Removal of these components in the growth medium decreased the concentration 
of extracellular polysaccharides by 68 to 79%. The concentration of extracellular 
polysaccharides was minimized with growth in EM medium with 2.0 mg/ml lecithin 
and without lactose (Table 2) . 
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Table 2. Levels of extracellular polysaccharides produced by Eubacterium 
coprostanoligenes as grown in selected test media 
Sample 
BC 
BC+ 1 .5% Pyruvate 
BC+ 1 .5% Pyruvate & 1.5% Lactose 
EM + Cholesterol and Lactose 
EM-No Lactose 
EM-No Lactose-No Cholesterol 
EMO* 
EMO+Phosphate Buffer-No Lactose* 
EMO-No Lactose 
Escherichia coli K-12 
Total extracellular 
polysaccharide index 
(µg/ml) 
26.6 
33.4 
40.7 
22.7 
4.3 
7.2 
15.5 
4.5 
6.2 
1.8 
*EMO = Optimized EM medium with 2.0 mg/ml lecithin 
Cell yield 
(µg/ml of cells) 
407 
551 
499 
883 
879 
886 
1070 
1081 
1062 
1916 
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Whole cell kinetics of cholesterol reduction 
Initial kinetic studies of cholesterol reduction revealed a problem with 
substrate accessibility. Optimal whole cell activity required cholesterol/lecithin 
micelles (Fig. 2). Michaelis-Menten plots of whole cell assays utilizing 
cholesterol/lecithin micelles over blended cholesterol/lecithin showed a four-fold 
increase of activity. Blended cholesterol/lecithin showed a maximal rate of 
cholesterol reductase activity of 0. 7 nmol/min·mg cell protein at a substrate 
concentration of 2 mM (Fig. 2). However, the kinetic data obtained with the use of 
blended cholesterol-lecithin as substrate did fit into conventional kinetic models. 
Using cholesterol/lecithin micelles, whole-cell cholesterol reductase activity 
showed an apparent KM of 111 µM and an apparent V max of 2.9 nmol cholesterol 
reduced/ min·mg cell protein (Fig. 2). 
The proposed intermediates of the multiple-step reduction of cholesterol to 
coprostanol, 4-cholesten-3-one and coprostan-3-one, were identified (Table 1 ). 
However, cholesten-3-one and coprostan-3-one were only detected in whole cells 
showing high cholesterol reductase activity {Table 1 ). 
Cell-free/fractionation studies 
Highest cell-free rates of cholesterol reductase activity were obtained with 
crude lysates using NADH or ascorbate as a reductant (Table 3). The cholesterol 
reductase activity was observed in membrane fractions (Table 4). The loss of 
activity between the cell-free fraction and membrane fraction could not be 
recovered by addition of the soluble fraction. The highest cholesterol reduction 
activity in washed membrane fractions was observed when ascorbate and methyl 
viologen were used as the reductant/redox dye combination (Table 4) . 
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0 
0 100 200 
Cholesterol (nM) 1/Cholesterol (nM) 
Figure 2. Michaelis-Menten (A) and Lineweaver-Burk (8) plots of cholesterol 
reduction by E. coprostanoligenes; assayed using blended 
cholesterol (• ) and cholesterol-lecithin micelles (0). 
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Table 3. Cell-free cholesterol reductase assays utilizing cell-free 
lysates. 
Reductant 
Pyruvate* 
NADH 
NADH 
NADH 
NADH plus dithionite 
Succinate 
Succinate 
Succinate 
Lumiflavin 
Lumiflavin 
Lumiflavin 
Ascorbate 
Ascorbate 
Ascorbate 
Ascorbate 
Redox Dye 
Benzyl Viologen 
Methyl Viologen 
Benzyl Viologen 
Methyl Viologen 
EDTA 
EDTA plus Benzyl 
Viologen 
EDTA plus Methyl 
Viologen 
Benzyl Viologen 
Methyl Viologen 
TMPD 
Benzyl Viologen 
Methyl Viologen 
Cholesterol 
Reductase 
Actitvity 
(pmol/min/mg 
protein) 
102 
0 
0 
576 
0 
48 
0 
90 
0 
50 
170 
0 
350 
230 
90 
88 
63 
Sodium Thioglycolate O 
Sodium Thioglycolate Benzyl Viologen O 
Sodium Thioglycolate Methyl Viologen 230 
* = No stimulation of cholesterol reductase activity was observed 
with the addition of methyl or benzyl viologen. 
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Table 4. Reductant/redox dye screenings of cholesterol reduction by membrane 
fractions of E. coprostanoligenes. 
Reductant 
Sodium Thioglycolate 
Sodium Thioglycolate+Pyruvate 
Sodium Thioglycolate +H2 
Pyruvate 
Pyruvate + H2 
Ascorbate 
Dithionite 
Dithionite 
NADH + H+ 
NADH + H+ 
NADH + H+ 
Redox Dye 
Benzyl Viologen 
Methyl Viologen 
Benzyl Viologen 
Methyl Viologen 
Cholesterol 
Reductase Activity 
(pmol/min • mg 
protein) 
119 
124 
149 
120 
166 
245 
56 
79 
0 
145 
158 
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Steroid/sterol kinetics 
The cholesterol reductase activity from E. coprostanoligenes demonstrated 
a broad specificity for sterol/steroid derivatives other than cholesterol (Table 5). 
The rate of reduction for both coprostan-3-one and 4-Cholesten-3-one were 
similar to the rate of cholesterol reductase activity (Table 5). 4-Cholesten-3-one 
has been identified as a stable intermediate in a multiple step mechanism of the 
chemical reduction of cholesterol to coprostanol by Bjorkhem et al. (Bjorkhem et al. , 
1973). However, Bjorkhem's studies were conducted with mixed cultures. 
The rates of corticosterone, progesterone, 17-hydroxyprogesterone, and 
anhydroxyprogesterone reduction activity were somewhat lower than those 
observed with cholesterol derivatives. There was no reduction of 17-
hydroxypregnenalone or B-sitosterol by whole cells of E. coprostanoligenes (Table 
5). 
The sterol/steroid reductase activity of E. coprostanoligenes showed high 
affinity for the steroids and sterols assayed (Table 5). Cholesterol appears to be 
the preferred substrate (Table 5). The affinity for cholesterol and rates of 
cholesterol reductase activity are significantly higher than previously reported 
bacterial reduction rates (Mott and Brinkley, 1979; Freier et al. , 1994). 4-
Cholesten-3-one and coprostan-3-one, proposed intermediates in a multiple-step 
reduction of cholesterol, were both converted to coprostanol at rates comparable 
to that of cholesterol (Table 5). 
Corticosterone and progesterone were also chemically reduced by washed 
whole cells of E. coprostanoligenes (Table 5) . Although the Vmax app.values 
obtained were somewhat lower than that of the cholesterol derivatives, the enzyme 
showed higher substrate affinities. 
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Table 5. Steroid/sterol reduction by E. coprostanoligenes. 
Steroid/Sterol Reductase 
Activity 
Steroid/Sterol 
Rate * KM+ VMaxt 
Cholesterol 2.9 1 1 1 
4-Cholesten-3-one 2.5 63 
Coprostan-3-one 2.5 81 
Corticosterone 0.7 24 
Progesterone 0.5 28 
17-Hydroxyprogesterone 800 ND ND 
An hyd roxyprogeste ron e 615 ND ND 
B-Sitosterol 0 ND ND 
17-Hydroxy Pregnenalone 0 ND ND 
ND = Not Determined 
* = pmol/min·mg protein 
+ = µmol as calculated 
t = nmol/min·mg protein 
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Mixed substrate studies of sterol/steroid reduction by E. coprostanoligenes 
indicated that 4-cholesten-3-one and coprostan-3-one were intermediates in the 
reduction of cholesterol. When cholesterol and either 4-cholesten-3-one, 
coprostan-3-one or progesterone were added to reaction mixtures, a competitive 
type of inhibition was also observed (Figs. 3 - 5) . 
Discussion 
E. coprostanoligenes, unlike previously isolated strains of cholesterol-
reducing Eubacterium, does not require homogenized brain tissue or lipid extracts 
of brain for growth. Results of these studies illustrate that lecithin is also not 
required for growth. The growth of E. coprostanoligenes in a methanol-acetate 
based medium (i.e. MSM) yielded comparable growth and cholesterol reductase 
activity rates with cells cultured in the absence of lecithin. The minimal salts 
medium developed could serve as an alternative and more cost-effective medium. 
The acidogenic properties of E. coprostanoligenes when grown under 
methylotrophic conditions are very similar to acidogenic strains of Eubacterium 
limosum (Pacaud et al., 1986; Pacaud et al., 1986; Loubiere et al. , 1986; Sharak 
Genthner and Bryant, 1982). 
The lower rates of cholesterol reductase activity observed when E. 
coprostanoligenes was grown in MSM could be due to several reasons. The 
generation of energy and biomass by E. coprostanoligenes when grown in MSM 
may cause a shift in the reductant , from cholesterol to butyryl-CoA resulting in 
production of butyric acid (Pacaud et al. , 1986). Final culture pH might also play a 
role in the decreased cholesterol reduction rates as seen when lactose was used 
in the initial isolation media (Freier et al. , 1994; Freier, 1991 ). E. coprostanoligenes 
Figure 3. 
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-10 0 10 20 30 40 50 
1/(S)(mM) 
Lineweaver-Burk plots of cholesterol reduction by E. 
coprostanoligenes with increasing levels of 4-cholesten-3-
one (0-no addition; •-+ .01 mM 4-cholesten-3-one; 0 -+ 
.02 mM 4-cholesten-3-one; .A-+ .03 mM 4-cholesten-3-one) . 
Figure 4. 
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Lineweaver-Burk plots of cholesterol reduction by 
E. coprostanoligenes with increasing levels of coprostan-
3-one (0-no addition ; +-+ .04 mM coprostan-3-one; *-+ 
.05 mM coprostan-3-one; A-+ .06 mM coprostan-3-one; 0 -+ 
0.1 mM coprostan-3-one) . 
Figure 5. 
50 
c 2 ·a; 
e 
a. 
Ol 
E 1.5 c: .E 
::::. 
0 
E 
.s 
0 
~ ...... 
-10 0 10 20 30 40 50 
1/[S) (mM) 
Lineweaver-Burk plots of cholesterol reduction by E. 
coprostanoligenes with increasing levels of progesterone 
(0 -no addition; +-+ .01 mM progesterone; •-+ .025 mM 
progesterone; 6-+ .05 progesterone; * -+ .075 mM progesterone; 
A.-+ 0.1 mM progesterone; 0 -+ 0.2 mM progesterone). 
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is the second species of Eubacterium shown to be a facultative methylotroph. As a 
result , further research into other members of the genus Eubacterium may provide 
a variety of commercially applicable bacteria for large-scale acid production. 
The lecithin requirement in BC and EM media is still in question. The 
substitution of soy lecithin containing 97% phosphatidyl choline in place of less 
pure soy lecithin used in the EM medium resulted in a sharp decline in cell yields 
and lower levels of cholesterol reductase activity (Lulich and DiSpirito, 1994). 
Substitution of egg-yolk lecithin for soy lecithin confirmed that the growth 
requirement is not phosphatidyl choline but some other component in the crude 
lecithin mixture that is necessary for growth in EM-type media (Lulich and DiSpirito, 
1994). Attempts to isolate and optimize essential components were unsuccessful. 
Genetic analysis of E. coprostanoligenes have been hampered by poor 
plating efficiencies and small colony size (Freier, 1991 ). Many solid media 
combinations were tried in an effort to increase colony size and enhance plating 
efficiencies. Solid media variations of EM, BC, and MSM were tried with various 
liquid overlays consisting of either cholesterol , lecithin, or reductants. None of the 
combinations attempted resulted in any significant improvements in either colony 
size or overall plating efficiency (Lulich and DiSpirito, 1994). Different agars were 
also screened including incubation of plates under various atmospheric conditions 
which yielded no improvements as well (Lulich and DiSpirito, 1994). 
Detection of 4-cholesten-3-one and coprostan-3-one in washed-cell assays 
confirmed the multiple-step reduction mechanism proposed by Bjorkhem et al. 
(1973). These intermediates were only observed in assays showing high 
cholesterol reduction rates. In cells showing lower cholesterol reduction rates, the 
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rate of reduction to 5-cholesten-3-one must be equal to or less than the rate of 
isomerization to 4-cholesten-3-one. 
Lineweaver-Burk plots of mixed substrate studies of cholesterol and either 
4-cholesten-3-one, coprostan-3-one or progesterone showed a competitive type of 
inhibition (Figures 2-4). However, the lines did not cross on they-axes (Figures 2-
4). This shift was probably the result of substrate accessibility. Although the use of 
micellar substrates greatly enhanced activities, there still could be problems with 
substrate accessibility in this assay system or other factors may have affected the 
formation of substrate enzyme complexes. 
Cholesterol reductase activity is biochemically similar to a number of 
previously characterized related sterol and steroid degradation enzymes (Table 6). 
Like many bacterial cholesterol oxidases, the chemical reduction of cholesterol by 
E. coprostanoligenes involves the generation of 4-cholesten-3-one as a stable 
intermediate. Many of these bacteria will further metabolize 4-cholesten-3-one as 
a carbon and energy source via other enzymes with H20 and C02 as end products 
(Smith and Brooks, 1976). However, coprostanol is not further metabolized by E. 
coprostanoligenes, thus raising questions of the metabolic role of cholesterol 
reductase (Lulich and DiSpirito, 1994). When E. coprostanoligenes was cultured 
in media containing cholesterol, there was no increase in growth yields (Table 2). 
Cholesterol reductase activity also shows the broad substrate specificity 
observed with cholesterol oxidase (Smith and Brooks, 1976). Cholesterol oxidase 
will oxidize a number of sterols and steroids, but the rates are affected by side-
chain length and distribution of hydroxyl groups within the ring system (Smith and 
Brooks, 1976). Cholesterol reductase activity is also influenced by side chain 
length and hydroxyl group positioning (Table 5). Rates of sterol reduction by E. 
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Table 6. Properties of sterol/steroid oxidzing and reducing enzymes 
characterized from various organisms. 
Organism Enzyme Primary Vmax * KMapp t Ref. 
Substrate 
Eubacterium sterol reductase cholesterol 2.9 111 This 
coprostanoligenes Study 
Eubacterium sp. 16-DHPR 16-dehydro- N/A 150 [53)(54] 
Strain 144 progesterone 
Eubacterium sp. 16a- 16a -hydroxy- N/A 250-520 [53)(54] 
Strain 144 dehydroxylase progesterone 
Eubacterium sp. 7a-hydroxysteroid bile acids with 601 4-20 [55] 
VPI 12708 dehyd rogenase 7-a hydroxyl group 
Eubacterium sp. cholic and cheno- 674 25 [56] 
VPI 12708 deoxycholic acids 
Streptomyces cholesterol cholesterol ,3B- 78 450-670 [57] 
vio/ascens oxidase hydroxysteroids 
Nocardia 18.5 2.9-7 [9][10](18] 
erythropolis 
Schizophyllum 10.4 330 [58) 
commune 
Brevibacterium 11 .3 2.9 [10)(14] 
sterolicum 
Pseudomonas 6.4 29 [10] 
testosteroni 
* = nmol/min· mg protein 
t= µmol as calculated 
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coprostanoligenes were also similar to the bile-acid and sterol hydroxylases and 
reductases characterized in other strains of Eubacterium (Table 6). 
Although cholesterol oxidase has been more extensively studied, attempts 
to use cholesterol oxidase in food systems to lower levels of cholesterol have not 
been successful (Aihara et al. , 1988; Smith et al., 1991 ; Suzuki et al. , 1986; Brigidi 
et al., 1993). One of the major problems with cholesterol oxidase is the generation 
of 4-cholesten-3-one as a stable by-product. 4-Cholesten-3-one has been shown 
to cause nuclear aberrations when administered to mice and could pose a concern 
if present at high levels in food products (Suzuki et al. , 1986). 
The use of cholesterol reductase has several distinct advantages over 
previously studied cholesterol degrading systems. One is that cholesterol is 
exclusively reduced to coprostanol. Coprostanol, a neutral sterol, has been shown 
to be poorly absorbed by the human body (Bhattacharyya, 1986). Coprostanol, 
thought to represent some 50% of the total fecal sterols, has not been shown to be 
toxic (Bhattacharyya, 1986). The use of cholesterol reductase to lower levels of 
cholesterol in foods serves as a novel, natural and possibly economical alternative 
to the previously developed methods. 
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SUMMARY AND DISCUSSION 
This series of studies involved the biochemical characterization of a 
cholesterol-reducing enzyme from the obligate anaerobe Eubacterium 
coprostanoligenes. The work outlined in this thesis supports a previously 
proposed multiple-step model of the chemical reduction of cholesterol to 
coprostanol with the generation of several stable intermediates (Figure 1) 
(Bjorkhem et al. , 1973). 
The first series of studies involved the optimization of growth and cholesterol 
reductase activity. The original isolation media, although useful, made important 
biochemical studies difficult. The optimized growth medium developed not only 
increased cell yields by 62%, but also resulted in a 68-79% reduction in the 
amount of extracellular polysaccharides (Table 2) . With the optimized medium, 
there was also an increase in cholesterol reductase activity making the 
development of working whole-cell and cell-free assays more feasible {Table 1 ). 
The growth of E. coprostanoligenes on MSM media provided several 
advantages over modified EM and BC media. Lecithin is not required for growth, 
and comparble growth yields and cholesterol reduction rates were obtained. The 
minimal salts medium could serve as an alternate, more cost-effective medium. 
The lecithin requirement for EM and BC media is still in question. Obviously, some 
component of the less pure soy lecithin used is essential for growth of E. 
coprostanoligenes in these media. Attempts to isolate and optimize these essential 
components were unsuccessful. 
With an optimized growth medium, a whole-cell and a cell-free cholesterol 
reductase activity assay were developed. Whole-cell and cell-free cholesterol 
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reductase activity assays did not appear to be dependent upon other coupled 
enzymes such as NADH dehydrogenases, or related enzymes (Tables 3 , 4). 
Cholesterol reductase activity was localized to the membrane fraction and cell-free 
activities were somewhat lower than those obtained in whole-cell screens (Table 3, 
4) . The loss of activity could be due to sensitivity of cholesterol reductase to 
oxygen or the loss of necessary cofactor(s) during fractionation. 
The increased levels of cholesterol reductase activity resulted in the 
detection and elucidation of several intermediates (Table 1 ). 4-Cholesten-3-one 
and coprostan-3-one, proposed intermediates in the multiple step mechanism of 
chemical cholesterol reduction , were detected (Figure 1, Table 1 ). 5-Cholesten-3-
one, the third of the proposed intermediates in this mechanism was not detected 
during any assays performed. This could be due to the fact that in the proposed 
reduction model, the isomerization of 5-Cholesten-3-one to 4-Cholesten-3-one 
could happen quickly enough that detection within the established assay systems 
was not possible (Bjorkhem et al. , 1973). 
Cholesterol reductase activity showed high affinity for substrate with V max app 
and KM app values of 2.9 nmol cholesterol reduced/min-mg protein and 111 µM, 
respectively (Table 5, Figure 2). These measurements were made possible by the 
use of cholesterol/lecithin mixed micelles as the principal substrate delivery 
system. Chemical reduction of cholesterol to coprostanol followed Michealis-
Menten enzyme kinetic models when micellar solutions of substrates were used 
(Figure 2). Use of blended cholesterol/lecithin as a substrate not only resulted in 
lower whole-cell rates of cholesterol reduction, but the activity obtained did not 
follow many enzymatic models tested (Figure 2). The improved substrate delivery 
system has made further characterization of this novel enzyme system possible. 
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As shown in the cholesterol oxidase system, cholesterol reductase activity 
also has a broad substrate specificity. Cholesterol, along with 4-cholesten-3-one, 
and coprostan-3-one, were reduced to coprostanol by E. coprostanoligenes. Other 
substrates reduced by E.coprostanoligenes included corticosterone, progesterone, 
17-hydroxyprogesterone, and anhydroxyprogesterone (Table 5) . No activity was 
observed with B-sitosterol or 17-hydroxypregnenalone (Table 5) . The lack of 
activity with B-sitosterol suggests that side-chain positioning of terminal 
substituents as well as overall length of the side chain, may affect substrate binding 
and catalysis, as was seen with cholesterol oxidase (Smith and Brooks, 1976). 
Kinetic studies of chemcial cholesterol reduction with various substrates 
revealed a competitive type of inhibition (Figures 3, 4, 5) . These results, coupled 
with reduction of the intermediates 4-cholesten-3-one and coprostan-3-one to 
coprostanol, support the multiple-step, chemical reduction of cholesterol to 
coprostanol. The competitive type of inhibition observed shows that the chemical 
reduction of cholesterol to coprostanol is most likely a one-enzyme system. 
The accumulation of intermediates is probably due to the increased rate of 
growth of E. coprostanoligenes in optimized media. The intermediates likely 
accumulate until cholesterol , the preferred substrate, is consumed in active 
reaction mixtures. Once cholesterol is consumed, the conversion of the 
intermediates to coprostanol occurs. The artificial assay conditions probably alter 
the equilibrium state of enzyme and intermediates and have a profound effect upon 
the regulation of this system. 
The rates of chemical cholesterol reduction are comparable to a number of 
steroid/sterol oxidation/reduction systems (Table 7) . Use of cholesterol oxidase to 
reduce levels of cholesterol in food systems has shown little promise. One problem 
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of cholesterol oxidase is the endproducts that are generated in the oxidation of 
cholesterol. Hydrogen peroxide, a highly reactive endproduct, has been shown to 
impart off-flavors in test food systems while the other product, 4-cholesten-3-one, 
has been implicated in nuclear aberrations in mouse tissue (Smith et al. , 1991 ; 
Suzuki et al., 1986). 
Although 4-cholesten-3-one is produced during the reduction of cholesterol 
to coprostanol by cholesterol reductase, the intermediate is rapidly converted to 
coprostanol and is not present as a stable endproduct. Since over 98% of 
cholesterol within reaction mixtures is converted to coprostanol, questions 
concerning a metabolic role (if any) of cholesterol reductase have been raised . 
Coprostanol, the endproduct of cholesterol reduction , comprises some 50% of fecal 
sterols present in humans and has not demonstrated any toxic effects 
(Bhattacharyya, 1986). 
The use of cholesterol reductase in the reduction of cholesterol in food 
systems shows great promise. Other, non-biological methods, although effective, 
have been disappointing due to high costs of equipment and complexity of 
processes. Other cholesterol-degrading enzymes have been employed with 
limited results. Cholesterol reductase represents a novel and natural cholesterol-
lowering enzyme that is not only efficient, but does not generate any potential toxic 
end products. 
For commercial use of cholesterol reductase, further studies involving 
isolation and stabilization of component(s) of cholesterol reductase will be 
necessary. Isolation of purification of protein(s) of cholesterol reductase will further 
provide insight and a potential commercial use of this relatively unknown system in 
the reduction of cholesterol. 
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